Global Obesity Surgery Devices Market to Reach $12.5 Billion by 2030, According to VynZ Research

The global obesity surgery devices market is expected to reach $12.5 billion by 2030, according to a new report by VynZ Research. The market is expected to grow at a CAGR of 7.5% from 2023 to 2030.

Get a sample report for free:- https://www.vynzresearch.com/healthcare/obesity-surgery-devices-market/request-sample

The growth of the obesity surgery devices market is being driven by a number of factors, including:
The increasing prevalence of obesity worldwide
The rising demand for minimally invasive procedures
The growing acceptance of obesity surgery as a viable treatment option
The expanding regulatory approval of obesity surgery devices
The increasing investments in research and development of new obesity surgery devices

The North American region is expected to remain the largest market for obesity surgery devices throughout the forecast period. The high prevalence of obesity in the region, coupled with the well-developed healthcare infrastructure, are the key factors driving the growth of the market in North America.

The European region is expected to be the second-largest market for obesity surgery devices during the forecast period. The increasing awareness of the health risks associated with obesity and the growing demand for minimally invasive procedures are the key factors driving the growth of the market in Europe.

The Asia Pacific region is expected to be the fastest-growing market for obesity surgery devices during the forecast period. The increasing prevalence of obesity in the region, coupled with the growing disposable incomes and the rising demand for quality healthcare, are the key factors driving the growth of the market in the Asia Pacific region.

The key players in the global obesity surgery devices market include:
Medtronic
Johnson & Johnson
Abbott Laboratories
Boston Scientific
Intuitive Surgical
Bariatrix Unlimited
Ethicon (Johnson & Johnson)
Olympus
Conmed Corporation
Medtronic
S.I.M.S. Spa

These companies are focusing on developing new and innovative obesity surgery devices to meet the growing demand from patients and surgeons. For instance, in 2022, Medtronic launched the Hugo Robotic-Assisted Surgery System, which is the first robotic surgery system designed specifically for obesity surgery.

The obesity surgery devices market is a highly competitive market. The key players are focusing on differentiating their products and services through innovation and marketing. For instance, Johnson & Johnson is focusing on developing obesity surgery devices that are less invasive and have a shorter recovery time.

The obesity surgery devices market is expected to grow significantly in the coming years. The key factors driving the growth of the market include the increasing prevalence of obesity worldwide, the rising demand for minimally invasive procedures, and the growing acceptance of obesity surgery as a viable treatment option.

For In-depth analysis:- https://www.vynzresearch.com/healthcare/obesity-surgery-devices-market

About VynZ Research
VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. VynZ have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.

Contact Us:
Call: +91-996-028-8381
Toll-Free (U.S. and Canada): +1-888-253-3960
Email: [email protected]
Website:- www.vynzresearch.com